The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global DTaP and Tdap Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The DTaP and Tdap Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global DTaP and Tdap Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Adult accounting for % of the DTaP and Tdap Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While DTaP segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of DTaP and Tdap Vaccines include Sanofi Pasteur, GlaxoSmithKline, Protein Sciences Corporation, Novartis AG, and Seqirus, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
DTaP and Tdap Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
DTaP
Td
Tdap
Market segment by Application can be divided into
Adult
Pediatric
The key market players for global DTaP and Tdap Vaccines market are listed below:
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US, Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe DTaP and Tdap Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of DTaP and Tdap Vaccines, with price, sales, revenue and global market share of DTaP and Tdap Vaccines from 2019 to 2022.
Chapter 3, the DTaP and Tdap Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the DTaP and Tdap Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and DTaP and Tdap Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of DTaP and Tdap Vaccines.
Chapter 13, 14, and 15, to describe DTaP and Tdap Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The DTaP and Tdap Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global DTaP and Tdap Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Adult accounting for % of the DTaP and Tdap Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While DTaP segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of DTaP and Tdap Vaccines include Sanofi Pasteur, GlaxoSmithKline, Protein Sciences Corporation, Novartis AG, and Seqirus, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
DTaP and Tdap Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
DTaP
Td
Tdap
Market segment by Application can be divided into
Adult
Pediatric
The key market players for global DTaP and Tdap Vaccines market are listed below:
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US, Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe DTaP and Tdap Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of DTaP and Tdap Vaccines, with price, sales, revenue and global market share of DTaP and Tdap Vaccines from 2019 to 2022.
Chapter 3, the DTaP and Tdap Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the DTaP and Tdap Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and DTaP and Tdap Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of DTaP and Tdap Vaccines.
Chapter 13, 14, and 15, to describe DTaP and Tdap Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 DTaP and Tdap Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global DTaP and Tdap Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 DTaP
1.2.3 Td
1.2.4 Tdap
1.3 Market Analysis by Application
1.3.1 Overview: Global DTaP and Tdap Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Adult
1.3.3 Pediatric
1.4 Global DTaP and Tdap Vaccines Market Size & Forecast
1.4.1 Global DTaP and Tdap Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global DTaP and Tdap Vaccines Sales in Volume (2017-2028)
1.4.3 Global DTaP and Tdap Vaccines Price (2017-2028)
1.5 Global DTaP and Tdap Vaccines Production Capacity Analysis
1.5.1 Global DTaP and Tdap Vaccines Total Production Capacity (2017-2028)
1.5.2 Global DTaP and Tdap Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 DTaP and Tdap Vaccines Market Drivers
1.6.2 DTaP and Tdap Vaccines Market Restraints
1.6.3 DTaP and Tdap Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Product and Services
2.1.4 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Product and Services
2.2.4 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Protein Sciences Corporation
2.3.1 Protein Sciences Corporation Details
2.3.2 Protein Sciences Corporation Major Business
2.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Product and Services
2.3.4 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business
2.4.3 Novartis AG DTaP and Tdap Vaccines Product and Services
2.4.4 Novartis AG DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Seqirus
2.5.1 Seqirus Details
2.5.2 Seqirus Major Business
2.5.3 Seqirus DTaP and Tdap Vaccines Product and Services
2.5.4 Seqirus DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Merck Sharp & Dohme Corp
2.6.1 Merck Sharp & Dohme Corp Details
2.6.2 Merck Sharp & Dohme Corp Major Business
2.6.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product and Services
2.6.4 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Astellas Pharma US, Inc
2.7.1 Astellas Pharma US, Inc Details
2.7.2 Astellas Pharma US, Inc Major Business
2.7.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Product and Services
2.7.4 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Pfizer Inc
2.8.1 Pfizer Inc Details
2.8.2 Pfizer Inc Major Business
2.8.3 Pfizer Inc DTaP and Tdap Vaccines Product and Services
2.8.4 Pfizer Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business
2.9.3 Johnson & Johnson DTaP and Tdap Vaccines Product and Services
2.9.4 Johnson & Johnson DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Lanzhou Institute of Biological Products Co., Ltd
2.10.1 Lanzhou Institute of Biological Products Co., Ltd Details
2.10.2 Lanzhou Institute of Biological Products Co., Ltd Major Business
2.10.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Product and Services
2.10.4 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business
2.11.3 AstraZeneca DTaP and Tdap Vaccines Product and Services
2.11.4 AstraZeneca DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Emergent BioSolutions Inc
2.12.1 Emergent BioSolutions Inc Details
2.12.2 Emergent BioSolutions Inc Major Business
2.12.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Product and Services
2.12.4 Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 DTaP and Tdap Vaccines Breakdown Data by Manufacturer
3.1 Global DTaP and Tdap Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global DTaP and Tdap Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in DTaP and Tdap Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 DTaP and Tdap Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 DTaP and Tdap Vaccines Manufacturer Market Share in 2021
3.5 Global DTaP and Tdap Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and DTaP and Tdap Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global DTaP and Tdap Vaccines Market Size by Region
4.1.1 Global DTaP and Tdap Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global DTaP and Tdap Vaccines Revenue by Region (2017-2028)
4.2 North America DTaP and Tdap Vaccines Revenue (2017-2028)
4.3 Europe DTaP and Tdap Vaccines Revenue (2017-2028)
4.4 Asia-Pacific DTaP and Tdap Vaccines Revenue (2017-2028)
4.5 South America DTaP and Tdap Vaccines Revenue (2017-2028)
4.6 Middle East and Africa DTaP and Tdap Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global DTaP and Tdap Vaccines Sales in Volume by Type (2017-2028)
5.2 Global DTaP and Tdap Vaccines Revenue by Type (2017-2028)
5.3 Global DTaP and Tdap Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global DTaP and Tdap Vaccines Sales in Volume by Application (2017-2028)
6.2 Global DTaP and Tdap Vaccines Revenue by Application (2017-2028)
6.3 Global DTaP and Tdap Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America DTaP and Tdap Vaccines Sales by Type (2017-2028)
7.2 North America DTaP and Tdap Vaccines Sales by Application (2017-2028)
7.3 North America DTaP and Tdap Vaccines Market Size by Country
7.3.1 North America DTaP and Tdap Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America DTaP and Tdap Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe DTaP and Tdap Vaccines Sales by Type (2017-2028)
8.2 Europe DTaP and Tdap Vaccines Sales by Application (2017-2028)
8.3 Europe DTaP and Tdap Vaccines Market Size by Country
8.3.1 Europe DTaP and Tdap Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe DTaP and Tdap Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific DTaP and Tdap Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific DTaP and Tdap Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific DTaP and Tdap Vaccines Market Size by Region
9.3.1 Asia-Pacific DTaP and Tdap Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific DTaP and Tdap Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America DTaP and Tdap Vaccines Sales by Type (2017-2028)
10.2 South America DTaP and Tdap Vaccines Sales by Application (2017-2028)
10.3 South America DTaP and Tdap Vaccines Market Size by Country
10.3.1 South America DTaP and Tdap Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America DTaP and Tdap Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa DTaP and Tdap Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa DTaP and Tdap Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa DTaP and Tdap Vaccines Market Size by Country
11.3.1 Middle East & Africa DTaP and Tdap Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa DTaP and Tdap Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of DTaP and Tdap Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of DTaP and Tdap Vaccines
12.3 DTaP and Tdap Vaccines Production Process
12.4 DTaP and Tdap Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 DTaP and Tdap Vaccines Typical Distributors
13.3 DTaP and Tdap Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global DTaP and Tdap Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global DTaP and Tdap Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur DTaP and Tdap Vaccines Product and Services
Table 6. Sanofi Pasteur DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Major Business
Table 9. GlaxoSmithKline DTaP and Tdap Vaccines Product and Services
Table 10. GlaxoSmithKline DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Protein Sciences Corporation Basic Information, Manufacturing Base and Competitors
Table 12. Protein Sciences Corporation Major Business
Table 13. Protein Sciences Corporation DTaP and Tdap Vaccines Product and Services
Table 14. Protein Sciences Corporation DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 16. Novartis AG Major Business
Table 17. Novartis AG DTaP and Tdap Vaccines Product and Services
Table 18. Novartis AG DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Seqirus Basic Information, Manufacturing Base and Competitors
Table 20. Seqirus Major Business
Table 21. Seqirus DTaP and Tdap Vaccines Product and Services
Table 22. Seqirus DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Merck Sharp & Dohme Corp Basic Information, Manufacturing Base and Competitors
Table 24. Merck Sharp & Dohme Corp Major Business
Table 25. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product and Services
Table 26. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Astellas Pharma US, Inc Basic Information, Manufacturing Base and Competitors
Table 28. Astellas Pharma US, Inc Major Business
Table 29. Astellas Pharma US, Inc DTaP and Tdap Vaccines Product and Services
Table 30. Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Inc Major Business
Table 33. Pfizer Inc DTaP and Tdap Vaccines Product and Services
Table 34. Pfizer Inc DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 36. Johnson & Johnson Major Business
Table 37. Johnson & Johnson DTaP and Tdap Vaccines Product and Services
Table 38. Johnson & Johnson DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Lanzhou Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 40. Lanzhou Institute of Biological Products Co., Ltd Major Business
Table 41. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Product and Services
Table 42. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Major Business
Table 45. AstraZeneca DTaP and Tdap Vaccines Product and Services
Table 46. AstraZeneca DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Emergent BioSolutions Inc Basic Information, Manufacturing Base and Competitors
Table 48. Emergent BioSolutions Inc Major Business
Table 49. Emergent BioSolutions Inc DTaP and Tdap Vaccines Product and Services
Table 50. Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global DTaP and Tdap Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 52. Global DTaP and Tdap Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in DTaP and Tdap Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global DTaP and Tdap Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and DTaP and Tdap Vaccines Production Site of Key Manufacturer
Table 56. DTaP and Tdap Vaccines New Entrant and Capacity Expansion Plans
Table 57. DTaP and Tdap Vaccines Mergers & Acquisitions in the Past Five Years
Table 58. Global DTaP and Tdap Vaccines Sales by Region (2017-2022) & (K Units)
Table 59. Global DTaP and Tdap Vaccines Sales by Region (2023-2028) & (K Units)
Table 60. Global DTaP and Tdap Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 61. Global DTaP and Tdap Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 62. Global DTaP and Tdap Vaccines Sales by Type (2017-2022) & (K Units)
Table 63. Global DTaP and Tdap Vaccines Sales by Type (2023-2028) & (K Units)
Table 64. Global DTaP and Tdap Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 65. Global DTaP and Tdap Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 66. Global DTaP and Tdap Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 67. Global DTaP and Tdap Vaccines Price by Type (2023-2028) & (USD/Unit)
Table 68. Global DTaP and Tdap Vaccines Sales by Application (2017-2022) & (K Units)
Table 69. Global DTaP and Tdap Vaccines Sales by Application (2023-2028) & (K Units)
Table 70. Global DTaP and Tdap Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 71. Global DTaP and Tdap Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 72. Global DTaP and Tdap Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 73. Global DTaP and Tdap Vaccines Price by Application (2023-2028) & (USD/Unit)
Table 74. North America DTaP and Tdap Vaccines Sales by Country (2017-2022) & (K Units)
Table 75. North America DTaP and Tdap Vaccines Sales by Country (2023-2028) & (K Units)
Table 76. North America DTaP and Tdap Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 77. North America DTaP and Tdap Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 78. North America DTaP and Tdap Vaccines Sales by Type (2017-2022) & (K Units)
Table 79. North America DTaP and Tdap Vaccines Sales by Type (2023-2028) & (K Units)
Table 80. North America DTaP and Tdap Vaccines Sales by Application (2017-2022) & (K Units)
Table 81. North America DTaP and Tdap Vaccines Sales by Application (2023-2028) & (K Units)
Table 82. Europe DTaP and Tdap Vaccines Sales by Country (2017-2022) & (K Units)
Table 83. Europe DTaP and Tdap Vaccines Sales by Country (2023-2028) & (K Units)
Table 84. Europe DTaP and Tdap Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe DTaP and Tdap Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe DTaP and Tdap Vaccines Sales by Type (2017-2022) & (K Units)
Table 87. Europe DTaP and Tdap Vaccines Sales by Type (2023-2028) & (K Units)
Table 88. Europe DTaP and Tdap Vaccines Sales by Application (2017-2022) & (K Units)
Table 89. Europe DTaP and Tdap Vaccines Sales by Application (2023-2028) & (K Units)
Table 90. Asia-Pacific DTaP and Tdap Vaccines Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific DTaP and Tdap Vaccines Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific DTaP and Tdap Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific DTaP and Tdap Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific DTaP and Tdap Vaccines Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific DTaP and Tdap Vaccines Sales by Type (2023-2028) & (K Units)
Table 96. Asia-Pacific DTaP and Tdap Vaccines Sales by Application (2017-2022) & (K Units)
Table 97. Asia-Pacific DTaP and Tdap Vaccines Sales by Application (2023-2028) & (K Units)
Table 98. South America DTaP and Tdap Vaccines Sales by Country (2017-2022) & (K Units)
Table 99. South America DTaP and Tdap Vaccines Sales by Country (2023-2028) & (K Units)
Table 100. South America DTaP and Tdap Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 101. South America DTaP and Tdap Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 102. South America DTaP and Tdap Vaccines Sales by Type (2017-2022) & (K Units)
Table 103. South America DTaP and Tdap Vaccines Sales by Type (2023-2028) & (K Units)
Table 104. South America DTaP and Tdap Vaccines Sales by Application (2017-2022) & (K Units)
Table 105. South America DTaP and Tdap Vaccines Sales by Application (2023-2028) & (K Units)
Table 106. Middle East & Africa DTaP and Tdap Vaccines Sales by Region (2017-2022) & (K Units)
Table 107. Middle East & Africa DTaP and Tdap Vaccines Sales by Region (2023-2028) & (K Units)
Table 108. Middle East & Africa DTaP and Tdap Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa DTaP and Tdap Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa DTaP and Tdap Vaccines Sales by Type (2017-2022) & (K Units)
Table 111. Middle East & Africa DTaP and Tdap Vaccines Sales by Type (2023-2028) & (K Units)
Table 112. Middle East & Africa DTaP and Tdap Vaccines Sales by Application (2017-2022) & (K Units)
Table 113. Middle East & Africa DTaP and Tdap Vaccines Sales by Application (2023-2028) & (K Units)
Table 114. DTaP and Tdap Vaccines Raw Material
Table 115. Key Manufacturers of DTaP and Tdap Vaccines Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. DTaP and Tdap Vaccines Typical Distributors
Table 119. DTaP and Tdap Vaccines Typical Customers
List of Figures
Figure 1. DTaP and Tdap Vaccines Picture
Figure 2. Global DTaP and Tdap Vaccines Revenue Market Share by Type in 2021
Figure 3. DTaP
Figure 4. Td
Figure 5. Tdap
Figure 6. Global DTaP and Tdap Vaccines Revenue Market Share by Application in 2021
Figure 7. Adult
Figure 8. Pediatric
Figure 9. Global DTaP and Tdap Vaccines Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global DTaP and Tdap Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global DTaP and Tdap Vaccines Sales (2017-2028) & (K Units)
Figure 12. Global DTaP and Tdap Vaccines Price (2017-2028) & (USD/Unit)
Figure 13. Global DTaP and Tdap Vaccines Production Capacity (2017-2028) & (K Units)
Figure 14. Global DTaP and Tdap Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. DTaP and Tdap Vaccines Market Drivers
Figure 16. DTaP and Tdap Vaccines Market Restraints
Figure 17. DTaP and Tdap Vaccines Market Trends
Figure 18. Global DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2021
Figure 19. Global DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2021
Figure 20. DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 DTaP and Tdap Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 DTaP and Tdap Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 23. Global DTaP and Tdap Vaccines Sales Market Share by Region (2017-2028)
Figure 24. Global DTaP and Tdap Vaccines Revenue Market Share by Region (2017-2028)
Figure 25. North America DTaP and Tdap Vaccines Revenue (2017-2028) & (USD Million)
Figure 26. Europe DTaP and Tdap Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific DTaP and Tdap Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. South America DTaP and Tdap Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa DTaP and Tdap Vaccines Revenue (2017-2028) & (USD Million)
Figure 30. Global DTaP and Tdap Vaccines Sales Market Share by Type (2017-2028)
Figure 31. Global DTaP and Tdap Vaccines Revenue Market Share by Type (2017-2028)
Figure 32. Global DTaP and Tdap Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global DTaP and Tdap Vaccines Sales Market Share by Application (2017-2028)
Figure 34. Global DTaP and Tdap Vaccines Revenue Market Share by Application (2017-2028)
Figure 35. Global DTaP and Tdap Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America DTaP and Tdap Vaccines Sales Market Share by Type (2017-2028)
Figure 37. North America DTaP and Tdap Vaccines Sales Market Share by Application (2017-2028)
Figure 38. North America DTaP and Tdap Vaccines Sales Market Share by Country (2017-2028)
Figure 39. North America DTaP and Tdap Vaccines Revenue Market Share by Country (2017-2028)
Figure 40. United States DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe DTaP and Tdap Vaccines Sales Market Share by Type (2017-2028)
Figure 44. Europe DTaP and Tdap Vaccines Sales Market Share by Application (2017-2028)
Figure 45. Europe DTaP and Tdap Vaccines Sales Market Share by Country (2017-2028)
Figure 46. Europe DTaP and Tdap Vaccines Revenue Market Share by Country (2017-2028)
Figure 47. Germany DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific DTaP and Tdap Vaccines Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific DTaP and Tdap Vaccines Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific DTaP and Tdap Vaccines Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific DTaP and Tdap Vaccines Revenue Market Share by Region (2017-2028)
Figure 56. China DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America DTaP and Tdap Vaccines Sales Market Share by Type (2017-2028)
Figure 63. South America DTaP and Tdap Vaccines Sales Market Share by Application (2017-2028)
Figure 64. South America DTaP and Tdap Vaccines Sales Market Share by Country (2017-2028)
Figure 65. South America DTaP and Tdap Vaccines Revenue Market Share by Country (2017-2028)
Figure 66. Brazil DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa DTaP and Tdap Vaccines Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa DTaP and Tdap Vaccines Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa DTaP and Tdap Vaccines Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa DTaP and Tdap Vaccines Revenue Market Share by Region (2017-2028)
Figure 72. Turkey DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa DTaP and Tdap Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of DTaP and Tdap Vaccines in 2021
Figure 77. Manufacturing Process Analysis of DTaP and Tdap Vaccines
Figure 78. DTaP and Tdap Vaccines Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
